2013
DOI: 10.1007/s12291-013-0312-5
|View full text |Cite
|
Sign up to set email alerts
|

Non-Invasive Biomarker in Prostate Carcinoma: A Novel Approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
9
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
6
1

Relationship

6
1

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 12 publications
0
9
0
Order By: Relevance
“…Further, we have also observed association of elevated pro-inflammatory IL-18 levels with disease progression (TNM staging and stages I, II, III, IV) and also elevated in tobacco exposed patients of carcinoma [3,6,7]. Additionally, levels for stages III and IV were significantly higher in all modes except in tobacco chewers of stage III patients, although the levels were higher than stage II.…”
mentioning
confidence: 81%
“…Further, we have also observed association of elevated pro-inflammatory IL-18 levels with disease progression (TNM staging and stages I, II, III, IV) and also elevated in tobacco exposed patients of carcinoma [3,6,7]. Additionally, levels for stages III and IV were significantly higher in all modes except in tobacco chewers of stage III patients, although the levels were higher than stage II.…”
mentioning
confidence: 81%
“…Several studies have shown that the modulation of inflammation by intravenous vitamin C correlated with decrease in tumour marker levels [186][187][188]. Studies conducted on human subjects reported that that plasma vitamin C and dietary intakes of vitamin C are inversely associated with some markers of the acute phase response and haemostasis that have been associated with greater risk of CVD and non-vascular disease.…”
Section: Vitamin C and Immunitymentioning
confidence: 99%
“…The AP-1 transcription factor is a regulator of processes essential for normal growth and development as well as carcinogenesis. Similarly, pro-inflammatory and anti-inflammatory interleukin's genotypes and gene expression have established their role in survival of prostate cancer patients [3][4][5]. Thus molecular diagnostics is going to swing the whole paradigm of screening and treatment.…”
Section: Molecular Diagnosis: Present Statusmentioning
confidence: 99%